12:00 AM
May 05, 2008
 |  BC Week In Review  |  Clinical News  |  Regulatory

14-type high-risk HPV test regulatory update

Third Wave submitted a PMA to FDA for its 14-type high-risk HPV test for use in conjunction with a Pap test to detect 14 types...

Read the full 103 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >